114 related articles for article (PubMed ID: 33444688)
1. Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer.
Cheng Y; Meng Y; Li S; Cao D; Ben S; Qin C; Hua L; Cheng G
Gene; 2021 Mar; 774():145432. PubMed ID: 33444688
[TBL] [Abstract][Full Text] [Related]
2. Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk.
Cao D; Meng Y; Li S; Xin J; Ben S; Cheng Y; Wang M; Hua L; Cheng G
Cancer Med; 2020 Dec; 9(24):9462-9470. PubMed ID: 33068330
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer.
Zhu Q; Meng Y; Li S; Xin J; Du M; Wang M; Cheng G
Gene; 2022 Jan; 808():145953. PubMed ID: 34500048
[TBL] [Abstract][Full Text] [Related]
5. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
[TBL] [Abstract][Full Text] [Related]
7. Post genome-wide association studies functional characterization of prostate cancer risk loci.
Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
9. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
Lavender NA; Rogers EN; Yeyeodu S; Rudd J; Hu T; Zhang J; Brock GN; Kimbro KS; Moore JH; Hein DW; Kidd LC
BMC Med Genomics; 2012 Apr; 5():11. PubMed ID: 22546513
[TBL] [Abstract][Full Text] [Related]
10. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
[TBL] [Abstract][Full Text] [Related]
11. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
Zhang P; Tillmans LS; Thibodeau SN; Wang L
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
[TBL] [Abstract][Full Text] [Related]
13. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
14. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
[TBL] [Abstract][Full Text] [Related]
15. Novel CpG-SNPs in the gastric acid secretion pathway GNAI3 and susceptibility to gastric cancer.
Liu M; Li S; Du M; Chu H; Wang M; Zhang Z
Gene; 2020 Apr; 736():144447. PubMed ID: 32032744
[TBL] [Abstract][Full Text] [Related]
16. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
18. Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.
Li S; Xie L; Du M; Xu K; Zhu L; Chu H; Chen J; Wang M; Zhang Z; Gu D
Arch Toxicol; 2018 Jun; 92(6):1991-1999. PubMed ID: 29766219
[TBL] [Abstract][Full Text] [Related]
19. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
